MDMA-Assisted Psychotherapy

MDMA-assisted psychotherapy has shown promising results in clinical trials for post-traumatic stress disorder. The article asserts that lower therapeutic MDMA doses create internal security for revisiting difficult memories. The article says research discussed by Rick Doblin indicates lower MDMA dosages outperform high doses therapeutically. The article notes that MDMA-assisted psychotherapy is progressing through Phase 3 clinical trials but remains difficult to access globally. MDMA-assisted psychotherapy may increase difficult emotions and memories so they can be processed with clinician support. Challenging material in MDMA-assisted psychotherapy may cause unintended harms if not handled by appropriately skilled clinicians. The article says high MDMA doses can create overwhelming indiscriminate euphoria.